Jeff Kindler

Jeff Kindler is a business advisory board member at Excision BioTherapeutics. Jeff has also served as a venture partner at Lux Capital, where they advised the company on its investment activities in emerging technologies in the physical and life sciences. Prior to that, they were the chairman and CEO of Pfizer, where they led the company's $68 billion merger with Wyeth. Jeff also worked with former President Bill Clinton to help bring medicines to impoverished patients in the developing world through public-private pharmaceutical partnerships.

Jeff Kindler received their Juris Doctor (J.D.) from Harvard University, where they graduated Magna Cum Laude. Jeff also holds a Bachelor's Degree from Tufts University, where they graduated Summa Cum Laude.